Drug name - Bridion

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE44733 ORGANON SUB MERCK 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
Jan, 2026

(3 years from now)

CN1188428C ORGANON SUB MERCK -Mercapto-Cyclodextrin Derivative, Comprising Mercapto Cyclodextrin Derivatives, Pharmaceutical Compositions And Use Thereof
Nov, 2020

(1 year, 10 months ago)

CN1402737A ORGANON SUB MERCK Reverse Reagent Of 6-Mercapto-Cyclodextrin Derivative For Drug-Induced Neuromuscular Anesthesia
Nov, 2020

(1 year, 10 months ago)

IN200200787P4 ORGANON SUB MERCK 6-Mercapto-Cyclodextrin Derivatives: Reversal Agents For Drug-Induced Neuromuscular Block
Nov, 2020

(1 year, 10 months ago)

IN234112B ORGANON SUB MERCK 6-Mercapto-Cyclodextrin Derivatives: Reversal Agents For Drug-Induced Neuromuscular Block
Nov, 2020

(1 year, 10 months ago)

EP1259550A1 ORGANON SUB MERCK 6-Mercapto-Cyclodextrin Derivatives: Reversal Agents For Drug-Induced Neuromuscular Block
Jul, 2023

(9 months from now)

EP1259550B1 ORGANON SUB MERCK 6-Mercapto-Cyclodextrin Derivatives: Reversal Agents For Drug-Induced Neuromuscular Block
Jul, 2023

(9 months from now)

Drugs and Companies using SUGAMMADEX SODIUM ingredient

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) SOLUTION;INTRAVENOUS Prescription
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.